ER-100 targets glaucoma and NAION through epigenetic reprogramming, with Phase II trials advancing, highlighting potential economic and healthcare disruptions in anti-aging therapies. Life Biosciences...
Recent studies reveal MG53 (TRIM72) enhances muscle stem cell activation and reduces inflammation, offering a novel therapeutic target for sarcopenia with promising preclinical and early clinical resu...
Recent studies reveal aging microglia can promote amyloid-β aggregation, shifting Alzheimer’s pathology understanding and highlighting new therapeutic strategies targeting immune-brain interact...
Recent studies link IGFBP7 from senescent cells to reduced exercise benefits in older adults, with senolytic therapies offering new avenues for enhanced fitness and healthy aging interventions. IGFBP7...
An analysis of clonal hematopoiesis, a somatic mosaicism in blood cells linked to aging, cancer, and cardiovascular risks, exploring ethical challenges in screening. Recent studies highlight clonal he...
New research reveals Ube2g1 upregulation in hematopoietic stem cells drives immune senescence via tyrosine phosphorylation, offering insights for reversing age-related decline, based on Haematologica ...
New research identifies IRF7 as a critical driver of unstable atherosclerotic plaques, offering a potential therapeutic target to reduce cardiovascular events through innovative clinical trials and te...
Recent studies reveal CAR-T cells with lecanemab antibodies reduce amyloid plaques in mice, highlighting a shift towards personalized cell-based therapies for Alzheimer’s treatment. New research...
This article explores sEH inhibitors as a novel approach to reduce chronic inflammation without impairing immunity, based on 2023 research from sources like ‘Aging Cell’ and industry repor...
A 2025 preclinical study shows Bifidobacterium adolescentis reduces pulmonary fibrosis in aged mice via the gut-lung axis, highlighting potential probiotic therapies for hard-to-treat conditions like ...
